RYTM logo

Rhythm Pharmaceuticals (RYTM) Depreciation and amortization

annual D&A:

$1.56M-$195.00K(-11.09%)
December 31, 2024

Summary

  • As of today (June 19, 2025), RYTM annual depreciation & amortization is $1.56 million, with the most recent change of -$195.00 thousand (-11.09%) on December 31, 2024.
  • During the last 3 years, RYTM annual D&A has risen by +$405.00 thousand (+34.97%).
  • RYTM annual D&A is now -11.09% below its all-time high of $1.76 million, reached on December 31, 2023.

Performance

RYTM Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

quarterly D&A:

$383.00K$0.00(0.00%)
March 31, 2025

Summary

  • As of today (June 19, 2025), RYTM quarterly depreciation & amortization is $383.00 thousand, unchanged on March 31, 2025.
  • Over the past year, RYTM quarterly D&A has dropped by -$22.00 thousand (-5.43%).
  • RYTM quarterly D&A is now -16.19% below its all-time high of $457.00 thousand, reached on March 31, 2023.

Performance

RYTM quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

TTM D&A:

$1.54M-$22.00K(-1.41%)
March 31, 2025

Summary

  • As of today (June 19, 2025), RYTM TTM depreciation & amortization is $1.54 million, with the most recent change of -$22.00 thousand (-1.41%) on March 31, 2025.
  • Over the past year, RYTM TTM D&A has dropped by -$165.00 thousand (-9.67%).
  • RYTM TTM D&A is now -13.57% below its all-time high of $1.78 million, reached on June 30, 2023.

Performance

RYTM TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

RYTM Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-11.1%-5.4%-9.7%
3 y3 years+35.0%+9.4%+17.9%
5 y5 years+87.4%+129.3%+103.8%

RYTM Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-11.1%+35.0%-16.2%+9.4%-13.6%+17.9%
5 y5-year-11.1%+126.5%-16.2%+129.3%-13.6%+123.3%
alltimeall time-11.1%>+9999.0%-16.2%+609.3%-13.6%+2753.7%

RYTM Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$383.00K(0.0%)
$1.54M(-1.4%)
Dec 2024
$1.56M(-11.1%)
$383.00K(-0.5%)
$1.56M(-2.1%)
Sep 2024
-
$385.00K(-1.3%)
$1.60M(-3.4%)
Jun 2024
-
$390.00K(-3.7%)
$1.65M(-3.0%)
Mar 2024
-
$405.00K(-2.9%)
$1.71M(-3.0%)
Dec 2023
$1.76M(+5.1%)
$417.00K(-5.7%)
$1.76M(-1.4%)
Sep 2023
-
$442.00K(0.0%)
$1.78M(0.0%)
Jun 2023
-
$442.00K(-3.3%)
$1.78M(+0.2%)
Mar 2023
-
$457.00K(+3.4%)
$1.78M(+6.4%)
Dec 2022
$1.67M(+44.4%)
$442.00K(0.0%)
$1.67M(+7.5%)
Sep 2022
-
$442.00K(+0.9%)
$1.55M(+8.9%)
Jun 2022
-
$438.00K(+25.1%)
$1.43M(+9.3%)
Mar 2022
-
$350.00K(+7.7%)
$1.31M(+12.9%)
Dec 2021
$1.16M(+67.8%)
$325.00K(+3.2%)
$1.16M(+14.5%)
Sep 2021
-
$315.00K(-0.6%)
$1.01M(+16.5%)
Jun 2021
-
$317.00K(+57.7%)
$868.00K(+19.9%)
Mar 2021
-
$201.00K(+12.9%)
$724.00K(+4.9%)
DateAnnualQuarterlyTTM
Dec 2020
$690.00K(-17.3%)
$178.00K(+3.5%)
$690.00K(-1.8%)
Sep 2020
-
$172.00K(-0.6%)
$703.00K(-2.6%)
Jun 2020
-
$173.00K(+3.6%)
$722.00K(-4.5%)
Mar 2020
-
$167.00K(-12.6%)
$756.00K(-9.4%)
Dec 2019
$834.00K(+88.7%)
$191.00K(0.0%)
$834.00K(-2.7%)
Sep 2019
-
$191.00K(-7.7%)
$857.00K(+11.0%)
Jun 2019
-
$207.00K(-15.5%)
$772.00K(+23.3%)
Mar 2019
-
$245.00K(+14.5%)
$626.00K(+41.6%)
Dec 2018
$442.00K(+98.2%)
$214.00K(+101.9%)
$442.00K(+53.5%)
Sep 2018
-
$106.00K(+73.8%)
$288.00K(+21.5%)
Jun 2018
-
$61.00K(0.0%)
$237.00K(+3.0%)
Mar 2018
-
$61.00K(+1.7%)
$230.00K(+3.1%)
Dec 2017
$223.00K(+54.9%)
$60.00K(+9.1%)
$223.00K(+36.8%)
Sep 2017
-
$55.00K(+1.9%)
$163.00K(+50.9%)
Jun 2017
-
$54.00K(0.0%)
$108.00K(+100.0%)
Mar 2017
-
$54.00K
$54.00K
Dec 2016
$144.00K(>+9900.0%)
-
-
Dec 2015
$0.00
-
-

FAQ

  • What is Rhythm Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Rhythm Pharmaceuticals?
  • What is Rhythm Pharmaceuticals annual D&A year-on-year change?
  • What is Rhythm Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Rhythm Pharmaceuticals?
  • What is Rhythm Pharmaceuticals quarterly D&A year-on-year change?
  • What is Rhythm Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Rhythm Pharmaceuticals?
  • What is Rhythm Pharmaceuticals TTM D&A year-on-year change?

What is Rhythm Pharmaceuticals annual depreciation & amortization?

The current annual D&A of RYTM is $1.56M

What is the all time high annual D&A for Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals all-time high annual depreciation & amortization is $1.76M

What is Rhythm Pharmaceuticals annual D&A year-on-year change?

Over the past year, RYTM annual depreciation & amortization has changed by -$195.00K (-11.09%)

What is Rhythm Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of RYTM is $383.00K

What is the all time high quarterly D&A for Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals all-time high quarterly depreciation & amortization is $457.00K

What is Rhythm Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, RYTM quarterly depreciation & amortization has changed by -$22.00K (-5.43%)

What is Rhythm Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of RYTM is $1.54M

What is the all time high TTM D&A for Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals all-time high TTM depreciation & amortization is $1.78M

What is Rhythm Pharmaceuticals TTM D&A year-on-year change?

Over the past year, RYTM TTM depreciation & amortization has changed by -$165.00K (-9.67%)
On this page